Looking at the individual, attributable targets paints a more complex view than a typical headline consensus. Six targets stand out: Barclays at $0.30 (October 16, 2026), Maxim Group at $3.00 (September 17, 2026), Jefferies at $0.81 (July 7, 2026), and Stephens, Mizuho and Stifel each at $1.00 (dated between February and May 2026). Their arithmetic mean comes to about $1.19, rounding to the $1.20 central target referenced here.
This $0.30-to-$3.00 spread — a ten-fold difference — points to unusually deep disagreement among analysts. Several targets predate the stock's sharpest drops and have not been updated; data providers note that "price targets may not have had time to catch up" after the roughly 90% annual collapse. Barclays' $0.30 captures the most cautious stance, while Maxim's $3.00 reflects a turnaround bet. No number here should be viewed as an official published consensus.
Shares closed near $0.1341 on November 2, 2026, with a 52-week range of roughly $0.12 to $1.48. Reaching $1.20 would require a move of about 800%, which qualifies as very large — essentially a recovery scenario rather than a near-term catalyst. The path would likely depend on resolving debt obligations, stabilizing revenue, restoring profitability, and meeting Nasdaq's $1.00 minimum-bid-price rule for ten consecutive business days by March 22, 2027.
Management has moved aggressively to simplify the portfolio, selling international operations to private-equity firm Aurelius for roughly $323 million and the North American snacks business (Terra, Garden of Eatin') for about $115 million, with proceeds directed toward debt reduction. A smaller, North America-focused operation and roughly $16 million in targeted annualized cost savings could, under favorable conditions, help restore profitability and ease some pressure.
The challenges remain significant. Hain Celestial reported a $531 million loss for fiscal 2026, largely from a $496 million impairment, plus a further $21 million net loss in its first quarter. Its auditor, Ernst & Young, expressed doubt about the company's ability to continue as a going concern, and Bloomberg reported that the company is considering a possible Chapter 11 filing. Debt matures in December 2026 with refinancing still unresolved, and the stock has traded below Nasdaq's $1.00 minimum since February, leading to a transfer to the Nasdaq Capital Market and raising the possibility of a value-dilutive reverse stock split.
The stock sits just above its 52-week low near $0.12, with limited meaningful technical support below current levels. The $1.00 mark now serves as both a psychological and regulatory threshold rather than simple resistance: reclaiming and holding it for ten consecutive days is required for continued Nasdaq listing. Earlier highs near $1.48 remain well out of reach for now.
Analyst targets generally reflect a roughly 12-month research horizon, though the age of several HAIN targets makes that assumption particularly uncertain here. I am watching the next earnings report (scheduled for November 9, 2026), any resolution of the December 2026 debt maturity, restructuring or Chapter 11 developments, a possible reverse-stock-split decision, and progress toward regaining Nasdaq compliance by March 2027. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For traders navigating volatility like HAIN's, Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from shifting market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor positions, and spot changing trends more efficiently than manual screening. Exploring these signals can be a practical way to add a data-driven layer to your decision-making.
The $1.20 target is an arithmetic mean of six widely divergent analyst targets, not a forecast, and it sits roughly 800% above the current price — a reflection of how far HAIN has fallen. A move to that level would require successful debt resolution, a return to profitability, and survival as a listed company, none of which is assured given the going-concern warning, possible bankruptcy filing, and Nasdaq compliance deadline. The wide $0.30-to-$3.00 analyst range underscores how little agreement exists. The next earnings report, debt negotiations, and any restructuring news are the most important signposts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HAIN saw its Momentum Indicator move below the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 73 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HAIN turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 36 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
HAIN moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for HAIN entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +12.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where HAIN advanced for three days, in 162 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
HAIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.079) is normal, around the industry mean (7.698). P/E Ratio (-0.040) is within average values for comparable stocks, (6.538). Projected Growth (PEG Ratio) (1.223) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.039) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. HAIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of organic snack food and personal care products
Industry FoodMajorDiversified